查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561565

2024-2032 年按藥物類別、給藥途徑、配銷通路和地區分類的犬異位性皮膚炎市場報告

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球犬異位性皮膚IMARC Group市場規模達21億美元。

犬異位性皮膚炎（CAD）是一種由花粉、室內灰塵、昆蟲叮咬、草和食物成分等過敏原引起的犬過敏性皮膚病。這是一種遺傳傾向，通常影響六個月至三歲的狗。它通常影響動物的腹側腹部、口腔、眼睛、指間皮膚、耳廓、腕骨、肘部和會陰區域。 CAD 的特徵是出現多種症狀，例如過度抓癢、爪子、腋下和臉部周圍發炎和搔癢。可以透過免疫抑制劑、單克隆解剖學和糖皮質激素來治療。它們可以透過口服、注射和局部用藥的方式給藥。眾所周知，它在德國牧羊犬、拉布拉多犬、金毛獵犬和哈巴狗中非常普遍。

犬異位性皮膚炎市場趨勢：

全球範圍內家犬中 CAD 的發生率不斷增加，這是創造積極市場前景的關鍵因素之一。這可以歸因於環境條件的變化、空氣污染水平的上升以及長期接觸過敏原。此外，寵物主人對 CAD 早期症狀和體徵（如發紅、皮膚油膩和酵母味）的日益關注和認知不斷提高，正在推動市場成長。此外，單株抗體治療該疾病的廣泛採用也有利於市場成長。這些抗體有助於指導所需的免疫反應並平息疾病的傳播。與此一致的是，越來越多的獸醫、醫院和診所致力於為動物提供更好的護理，這對市場成長產生了積極影響。其他因素，包括政府實施各種限制在動物身上使用標籤外人類藥物的舉措，以及獸醫科學領域的廣泛研究和開發（R＆D），預計將推動市場成長。

本報告回答的關鍵問題：

  • 迄今為止，全球犬異位性皮膚炎市場表現如何，未來幾年又將如何表現？
  • COVID-19 對全球犬異位性皮膚炎市場有何影響？
  • 主要區域市場有哪些？
  • 根據藥品類別類型，市場的詳細情形如何？
  • 根據給藥途徑，市場的分化為何？
  • 基於配銷通路的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球犬異位性皮膚炎市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球犬異位性皮膚炎市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場細分：依藥物類別類型

  • 糖皮質激素
    • 市場趨勢
    • 市場預測
  • 免疫抑制劑
    • 市場趨勢
    • 市場預測
  • 單株抗體
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依管理途徑

  • 專題
    • 市場趨勢
    • 市場預測
  • 口服
    • 市場趨勢
    • 市場預測
  • 可注射
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 獸醫院
    • 市場趨勢
    • 市場預測
  • 寵物診所
    • 市場趨勢
    • 市場預測
  • 藥局和藥局
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AB Science
    • Bimeda Inc.
    • Bioceltix SA
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Phibro Animal Health Corporation
    • Toray Industries Inc.
    • Vetoquinol SA
    • Virbac
    • Zoetis Inc.
Product Code: SR112024A4700

The global canine atopic dermatitis market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.0 Billion by 2032, exhibiting a growth rate (CAGR) of 13.8% during 2024-2032.

Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals. CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs.

Canine Atopic Dermatitis Market Trends:

The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease. In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global canine atopic dermatitis market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class type, route of administration and distribution channel.

Breakup by Drug Class Type:

  • Glucocorticoids
  • Immunosuppressants
  • Monoclonal Antibody
  • Others

Breakup by Route of Administration:

  • Topical
  • Oral
  • Injectable

Breakup by Distribution Channel:

  • Veterinary Hospitals
  • Pet Clinics
  • Pharmacies and Drugstores
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global canine atopic dermatitis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global canine atopic dermatitis market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Canine Atopic Dermatitis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class Type

  • 6.1 Glucocorticoids
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Monoclonal Antibody
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Injectable
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Veterinary Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pet Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Pharmacies and Drugstores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AB Science
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Bimeda Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bioceltix SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Ceva Sante Animale
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Dechra Pharmaceuticals PLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Elanco Animal Health Incorporated
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Phibro Animal Health Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Toray Industries Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vetoquinol S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Virbac
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Zoetis Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2023
  • Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis
  • Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis
  • Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million US$), 2024-2032
  • Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure
  • Table 7: Global: Canine Atopic Dermatitis Market: Key Players